Vivani Medical, Inc.
NASDAQ:VANIMedical - Devices
+$0.02 today
- Market cap
- $94.71M
- Beta
- 3.29
- P/E (TTM)
- -3.5
- EPS (TTM)
- -$0.33
Volume 0.18M
Average 0.24M
VANI Account Payables
Amounts the company owes suppliers for goods and services received.
Vivani Medical, Inc.NASDAQ: VANI
Account Payables · Q1 FY2026 · quarter ended Mar 2026
Account payables rises 45.9% from a year ago
Account payables stood at $1.47M at the end of Q1 FY2026, up 45.9% from a year earlier and up 42.0% from the prior quarter. Over 3 fiscal years it compounded at -4.3% a year.
Context
- Account payables amounted to 3.5% of total assets at the end of Q1 FY2026, up 0.6 pp from a year earlier.
- Account payables increased in 2 of the last 3 fiscal years.
What to watch
Whether account payables keeps rising in the next quarterly balance sheet after a +45.9% change from a year earlier.
Sources:Balance SheetText generated from reported figures; not investment advice.
Account Payables history
USD · from the balance sheet
- Latest · FY2025
- 1.03M USD
- Year-over-year change
- +26.3%
- 4-year CAGR
- +38.4%
| Period | Period end | Account Payables | YoY change |
|---|---|---|---|
| FY2025 | 2025-12-31 | 1.03M | +26.3% |
| FY2024 | 2024-12-31 | 817K | +50.7% |
| FY2023 | 2023-12-31 | 542K | -54.0% |
| FY2022 | 2022-12-31 | 1.18M | +318.9% |
| FY2021 | 2021-12-31 | 281K | — |
Account Payables vs competitors
How VANI compares with its peers on the latest reported figures
- Peers report in different currencies, so account payables is compared through growth and share of total assets rather than absolute size.
- Its year-over-year change of +45.9% is the 4th highest of 8, against a peer median of -5.5%.
- Account payables amounts to 3.5% of total assets for VANI, versus a peer median of 1.0%.
| Company | Period | Latest balance | YoY | 3-year CAGR | % of assets |
|---|---|---|---|---|---|
| Mar 2026 | $7.22M USD | -16.8% | +44.0% | 14.0% | |
| Mar 2026 | $4.55M USD | +97.5% | +81.5% | 7.5% | |
| Mar 2026 | $2.29M USD | +86.7% | -5.7% | 1.0% | |
| Mar 2026 | $1.47M USD | +45.9% | -4.3% | 3.5% | |
| Mar 2026 | $1.09M USD | +483.3% | +63.9% | 1.4% | |
IMAImageneBio Inc | Mar 2026 | $568K USD | -29.4% | -11.7% | 0.4% |
| Mar 2026 | $481K USD | -5.5% | -41.2% | 0.2% | |
| Mar 2026 | CA$0 CAD | -100.0% | — | 0.0% | |
| Peer median (excluding VANI) | — | -5.5% | +19.2% | 1.0% | |
Competitors are the stored peer set for VANI. Fiscal calendars differ, so each company's latest period is shown. Text is generated from reported figures; not investment advice.
Balance Sheet
Vivani Medical, Inc.
NASDAQ:VANI
Intrinsic Alpha fair value
Locked
Current Price
$1.05
Unlock the intrinsic value to see where the current price sits on the valuation runway.
Valuation runway
LockedGet the intrinsic value and margin of safety with a free account.
Continue the stock analysis
Jump to another research area for this company.